Hyperleukocytosis complicating lonafarnib treatment in patients with chronic myelomonocytic leukemia. (Q45147335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Hyperleukocytosis complicating lonafarnib treatment in patients with chronic myelomonocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Buresh A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Perentesis J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Rimsza L

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Kurtin S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Heaton R

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sugrue M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

1 reference

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

308-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403569

5 January 2020

exact match

0 references

cites work

Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403569

Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403569

Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403569

Cytologic examination of broncho-alveolar fluid during the retinoic acid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403569

inferred from DOI database lookup

7 January 2021

based on heuristic

Retinoic acid syndrome during the treatment of acute myelomonocytic leukaemia with all-trans-retinoic acid and low-dose cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403569

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403569

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15538404%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 January 2020

0 references

1 reference